烏帕替尼抑制劑Upadacitinib (ABT-494) is a selective Janus kinase (JAK) 1 inhibitor, which is being studied for the treatment of several autoimmune disorders in the IC50 of 43 nM.
| 產(chǎn)品名稱(chēng)： | 烏帕替尼 | ||
| 英文名： | Upadacitinib | ||
| CAS NO.： | 1310726-60-3 | ||
| 分子式： | C17H19F3N6O | ||
| 分子量： | 380.367573022842 | ||
| 產(chǎn)品品牌： | targetmol | ||
| 產(chǎn)品規(guī)格： | 1mg | ||
